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OBJECTIVE: The objective of this study was to examine the separate and combined effects of tobacco and biomass
smoke exposure on pulmonary histopathology in rats.
INTRODUCTION: In addition to smoking, indoor pollution in developing countries contributes to the development
of respiratory diseases.
METHODS: Twenty-eight adult rats were divided into four groups as follows: control group (Group I, no exposure to
tobacco or biomass smoke), exposed to tobacco smoke (Group II), exposed to biomass smoke (Group III), and
combined exposure to tobacco and biomass smoke (Group IV). After six months the rats in all four groups were
sacrificed. Lung tissue samples were examined under light microscopy. The severity of pathological changes was
scored.
RESULTS: Group II differed from Group I in all histopathological alterations except intraparenchymal vascular
thrombosis. There was no statistically significant difference in histopathological changes between the subjects
exposed exclusively to tobacco smoke (Group II) and those with combined exposure to tobacco and biomass smoke
(Group IV). The histopathological changes observed in Group IV were found to be more severe than those in
subjects exposed exclusively to biomass smoke (Group III).
DISCUSSION: Chronic exposure to tobacco and biomass smoke caused an increase in severity and types of lung
injury.
CONCLUSION: Exposure to cigarette smoke caused serious damage to the respiratory system, particularly with
concomitant exposure to biomass smoke.
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INTRODUCTION
The harmful effects of tobacco smoke are well known and
have been demonstrated by experimental trials.
1 Organic
materials such as charcoal, dried dung, and firewood, which
are derived from plant residues and used as fuel, are
collectively called biomass. In developing countries, bio-
mass fuel is burned to obtain energy for daily necessities,
such as heating and cooking. The smoke from biomass fuel
contains noxious materials, including carbon monoxide
(CO), nitric oxide (NO), sulphur oxides (SO), formaldehyde,
polycyclic organic matter (POM), and benzopyrene. More
than 500 million people in the world are exposed to the
smoke and noxious molecules emitted from burning these
fuels.
2 Many studies reveal that exposure to biomass smoke
can markedly increase the prevalence of respiratory
disorders.
3-6
In Turkey, there is a high frequency of chronic obstructive
pulmonary disease (COPD) in women who have never
smoked but were exposed to biomass smoke.
7 The potential
mechanisms and radiological and functional effects of
biomass smoke exposure are investigated at our clinic.
8-11
We have examined the relative importance of biomass and
tobacco smoke exposures in the development of COPD.
12
The impact of passive smoking along with biomass smoke
exposure may have other implications in addition to
COPD.
13,14 There is not sufficient data demonstrating the
possible chronic effects of tobacco and biomass smoke
exposure together on the respiratory apparatus. The
objective of this study was to examine the separate and
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1081combined effects of tobacco and biomass smoke exposure
on pulmonary histopathology in rats.
MATERIALS AND METHODS
This study was approved by the Cumhuriyet University
Faculty of Medicine Animal Research Ethics Committee and
conducted in Cumhuriyet University laboratories between
December 2008 and July 2009.
Experimental animals
Twenty-eight adult male Winstar rats, weighing about
300 g each, were obtained from the laboratories of
Experimental Animals Research and Practice Centre,
Cumhuriyet University, Sivas. The animals were housed
in plastic cages with a floor area of 920 cm
2 (Type III,
Allentown Inc., USA) under standard laboratory conditions
(illuminated between 7:00 a.m. and 8:00 p.m., temperature
of 21¡2˚C, and relative humidity of 55%) and maintained
according to the recommendations in the ‘Guide for the
Care and Use of Laboratory Animals’ of the National
Institutes of Health.
15 When exposed to tobacco or biomass
smoke, the subjects were placed in a different room with
continuous ventilation. The study was initiated with four
groups and each group consisted of nine rats. Group I was
the control group, which was kept under standard
laboratory conditions with ventilation and was not exposed
to tobacco or biomass smoke, Group II was exposed to
tobacco smoke, Group III was exposed to biomass smoke,
and Group IV was exposed to tobacco and biomass smoke.
Two rats from Group II, one rat from Group III, and one rat
from Group IV died for unknown reasons. One rat from Group
III and one from Group IV were excluded from the study when
it was noticed that they were sick. At the end of the study two
rats from the control group were randomly excluded, equal-
izing the number of subjects in each group (n=7).
Exposure to tobacco smoke
The rats in Group II were placed in another room every
morning from 9:00 and 10:00 for 6 months. Smoke from 5
burning cigarettes was pumped into this ventilated room for
the hour. Every cigarette was kept burning for about 15–20
minutes. Ambient CO concentration was measured as
116¡23 ppm and oxygen saturation was measured as 20%
with the use of a GT series gas detector (Gas Measurement
Instruments, UK).
16,17
Exposure to biomass smoke
The rats in Group III were placed in another room every
morning from 9:00 and 10:00 for 6 months. In this ventilated
room, the smoke produced by burning approximately 500
grams of dried animal dung was dispersed into the
environment with a manual bellow (Figure 1) modified
from that used in previous studies.
18 The ambient CO
concentration and oxygen saturation were measured as
228¡30 ppm and 20%, respectively.
16,17 Finally, the rats in
Group IV were exposed to tobacco smoke between 11:00
a.m. and 12:00 a.m. and to biomass smoke between 14:00
p.m. and 15:00 p.m. every day for 6 months. Meanwhile,
ambient CO concentration was detected at 116¡23 ppm
and oxygen saturation was measured as 20%.
16,17 The
United States Environmental Protection Agency states that
the standard level for 8-hour average carbon monoxide
concentrations is 9 ppm and it has been reported that this
level can reach 10-500 ppm during cooking.
18 At the end of
six months, the rats in all 4 groups were sacrificed by
intraperitoneal injection of 200 mg/kg sodium pentothal.
Pathological examination
Lung tissue samples were fixed in a 10% formaldehyde
solution and embedded in paraffin blocks. From the paraffin
block of each tissue sample, 4-mm slices were cut. After
applying routine hematoxylin and eosin stain, prepared
materials were examined by light microscopy (Nikon
Eclipse 80i, Japan) by a pulmonary pathologist blinded to
treatment groups. The severity of pathological changes was
scored according to previously published methods that
were modified for this study.
19-21
The main parameters included perivascular and peri-
bronchial inflammation, parenchymal infiltration and fibro-
sis, intraparenchymal vascular congestion and thrombosis,
respiratory epithelial proliferation, nodular aggregation of
inflammatory cells, alveolar destruction, emphysematous
changes, alveolar macrophage count, interstitial deposit-
containing macrophage count, vascular wall thickness, and
tracheal alterations. These 13 pathological parameters were
graded in parallel, where 0 indicated no injury, 1 indicated
injury to 25% of the field, 2 indicated injury to 50% of the
field, 3 indicated injury to 75% of the field, and 4 indicated
diffuse injury, for a maximal total score of 52.
Lymphocytic infiltration was scored as 0 for no infiltra-
tion around small airways, 1 for minimal random infiltra-
tion, 2 (mild) for aggregate formation, 3 (moderate) for at
least two aggregates per low power field, and 4 (severe) for
more than two aggregates. Large lymphoid aggregates
localized around bronchovascular ramification sites and
large airways were not taken into consideration.
Macrophage count was scored as follows 1 for ,5 cells in
alveolar spaces, 2 for 5˚9 cells, 3 for $10 cells, and 4 for
abundant cells. When needed Masson’s trichrome stain was
used to identify fibrosis.
Statistics
All data from control and experimental groups were
transformed into numeric values and transferred to a
statistical software package (Statistical Package for Social
Sciences for Windows, version 14.0, SPSS Inc, USA). The
Kruskal–Wallis test wasused tothe comparefourgroups and
the Mann–Whitney U test was used to compare two groups.
A p value ,0.05 was considered statistically significant.
Figure 1 - Biomass smoke exposure in rats.
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1082RESULTS
Data from all histopathological examinations are pre-
sented in Table 1. Group II (exposed to tobacco smoke)
differed from Group I (control group) in all histopatholo-
gical parameters except intraparenchymal vascular throm-
bosis. Vascular wall thickness, perivascular leukocyte-rich
inflammation and interstitial inflammation were of moder-
ate severity in subjects exposed to tobacco smoke.
Peribronchial inflammation was prominent, especially the
presence of aggregates (Fig. 2 & 3). Furthermore, the
subjects in Group II exhibited alveolar destruction, emphy-
sematous changes, epithelial proliferation, and increased
alveolar macrophages, whereas control group did not.
As shown in Table 1, the subjects exposed to biomass
smoke alone (Group III) manifested higher levels of
perivascular inflammation, peribronchial inflammation,
parenchymal infiltration and fibrosis, nodular aggregation,
alveolar destruction, and emphysematous changes in
comparison to the control group. However, there were no
differences between the two groups in intraparenchymal
vascular thrombosis and congestion, respiratory epithelial
proliferation, alveolar and interstitial deposit-containing
macrophage counts, or vascular wall thickness.
Histopathological alterations were less severe for this group
compared to those in the group exposed to tobacco (Fig. 4).
Histopathological changes in Group IV (exposed to both
tobacco and biomass smoke) were more prominent than
those in the control group. Significant differences were
observed in all the parameters except respiratory epithelial
proliferation (Fig. 5).
With respect to histopathological changes, there was no
significant difference between the subjects exposed exclu-
sively to tobacco smoke (Group II) and those with combined
exposure to tobacco and biomass smoke (Group IV).
However, the histopathological changes observed in Group
IV were more severe than in those exposed exclusively to
Table 1 - Histopathological examination data for all treatment groups.
Control Cigarette Dried dung
Cigarette
+
Dried dung P
a P
b P
c p
d P
e P
f
perivascular
inflammation
0.00¡0.00 2.43¡0.79 1.57¡0.54 2.86¡0.38 ,0.001 0.001 0.001 0.001 0.383 0.002
peribronchial
inflammation
0.86¡0.38 2.71¡0.49 2.29¡0.49 2.71¡0.49 ,0.001 0.001 0.001 0.001 1.00 0.209
parenchymal
infiltration and
fibrosis
0.00¡0.00 2.43¡0.79 1.71¡0.76 3.00¡0.58 ,0.001 0.001 0.001 0.001 0.259 0.011
intraparenchymal
vascular congestion
1.14¡0.38 2.43¡0.54 1.57¡0.54 2.57¡0.54 0.001 0.002 0.209 0.001 0.710 0.017
intraparenchymal
vascular thrombosis
0.00¡0.00 0.71¡0.76 0.29¡0.49 1.14¡0.90 0.025 0.073 0.383 0.026 0.383 0.097
respiratory epithelial
proliferation
0.00¡0.00 1.71¡1.11 0.71¡1.11 0.43¡1.13 0.009 0.004 0.209 0.710 0.053 0.456
nodular aggregation 0.00¡0.00 1.43¡1.13 1.14¡0.90 1.71¡0.76 0.004 0.026 0.004 0.001 0.710 0.209
alveolar destruction 0.00¡0.00 1.43¡0.54 0.71¡0.49 1.57¡1.13 0.001 0.001 0.026 0.004 0.902 0.165
emphysematous
changes
0.00¡0.00 1.57¡0.54 0.71¡0.49 1.71¡0.95 ,0.001 0.001 0.026 0.001 1.00 0.073
alveolar macro-
phages (n)
0.00¡0.00 1.29¡0.76 0.57¡0.79 1.57¡0.54 0.002 0.004 0.209 0.001 0.535 0.038
interstitial
deposit-containing
macrophages
0.00¡0.00 0.86¡0.90 0.29¡0.49 1.14¡0.90 0.027 0.073 0.383 0.026 0.620 0.097
vascular wall
thickness
0.00¡0.00 2.43¡0.54 0.14¡0.38 2.43¡0.54 ,0.001 0.001 0.710 0.001 1.00 0.001
trachea 1.86¡1.46 0.71¡0.49 0.71¡0.95 0.86¡1.07 0.310
Mean score
g 4.43¡0.61 24.29¡2.19 13.14¡1.24 25.71¡2.31 ,0.001 0.001 ,0.001 0.001 0.710 0.001
aComparison among four groups (Kruskal-Wallis test).
bComparison between control and cigarette groups (Mann-Whitney U test).
cComparison between control and dried dung groups (Mann-Whitney U test).
dComparison between control and cigarette + dried dung groups (Mann-Whitney U test).
eComparison between cigarette and cigarette + dried dung groups (Mann-Whitney U test).
fComparison between dried dung and cigarette +dried dung (Mann-Whitney U test).
gChanges of each histopathological parameters were scored from 0 to 4, then summed for a maximum total score of 42. Data are shown as mean ¡ SEM.
Figure 2 - Histopathological findings in the control group (Group
I). No abnormalities were found (H&E, 640).
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1083Figure 3 - Histopathological findings in the cigarette smoke-exposed group (Group II). (a) peribronchial inflammation (arrow) (H&E,
620). (b) perivascular inflammation and vascular wall thickness (arrow) (H&E,620). (c) vascular wall thickness and calcification (arrow)
(H&E, 620). (d) parenchymal infiltration and fibrosis (arrow) (Masson’s trichrome, 620).
Figure 4 - Histopathological findings in the biomass smoke-exposed group (Group III). (a) peribronchial inflammation (arrow) (H&E,
610). (b) peribronchial, perivascular, and interstitial inflammation (arrows) (H&E, 640). (c) perivascular inflammation (arrow) (H&E,
640). (d) parenchymal infiltration and fibrosis (arrow). (Masson’s trichrome, 640).
Pulmonary toxicity of smoke in rats
Dogan OT et al.
CLINICS 2011;66(6):1081-1087
1084biomass smoke (Group III). These changes included perivas-
cular inflammation, parenchymal infiltration and fibrosis,
intraparenchymal vascular congestion, increased alveolar
macrophages, and vascular wall thickness.
DISCUSSION
Cigarette smoking, especially in industrialized countries, is
an important risk factor for COPD, coronary artery disease,
lung cancer, and several other diseases. Outdoor pollution in
developed countries and indoor pollution in developing
countries also contribute to the development of respiratory
diseases. The ongoing use of biomass as solid fuel for heating
and cooking in developing countries has been associated
with an increased risk for chronic respiratory diseases by
numerous clinical and epidemiological studies conducted in
Turkey and other countries.
22-27 Cigarette and biomass
smoke exert their harmful effects via oxidative stress.
9,28,29
Acute massiveexposure andchronic exposure toinhalational
irritants may have diverse pathological outcomes.
Significantly increased lung damage due to chronic exposure
has been demonstrated. Many experimental animal studies
reveal that the chronic effects of smoke, particularly from
cigarettes, cause very severe pathological changes.
30-34 In our
study, exposure to tobacco smoke (Group II) caused
differences in all histopathological parameters except intra-
parenchymal vascular thrombosis and bronchoalveolar
hemorrhage. Vascular wall thickness, perivascular leuko-
cyte-rich inflammation, and interstitial inflammation were of
moderate severity in this group. Peribronchial inflammation
was prominent, in particular with the formation of aggre-
gates (Fig. 3). Alveolar destruction, emphysematous changes,
epithelial proliferation, and alveolar macrophages were
increased in this group, consistent with the literature. When
guinea pigs were exposed to the smoke of 5 cigarettes a day
for 3 months lesions similar to human emphysema were
found.
31 In addition, when guinea pigs were exposed to
cigarette smoke for 12 months, functional losses and
structural emphysematous changes were found when lung
tissue was viewed ultra-microscopically.
33 Our study reveals
the development of alveolar destruction and emphysema,
which is in agreement with previous studies.
Exposure of rats to cigarette smoke results in small airway
wall muscular hyperplasia and fibrosis and vascular changes
associated with pulmonary hypertension.
32 Vascular changes
due to exposure of rats to cigarette smoke are associated with
pulmonary hypertension,
34,35 and these changes likely result
from hypertrophy of the vascular wall due to inflammation.
We found similar alterations, including perivascular inflam-
mation, vascular congestion, and vascular wall thickness, in
the group exposed to cigarette smoke. In the biomass smoke-
exposed group, only perivascular inflammation was present. It
was interesting to observe that intravascular thrombosis
occurred solely in the group with combined exposure but
not in the groups with exclusive exposures, suggesting that
multiple exposures may have more damaging effects and have
a synergistic effect on the development of pulmonary
hypertension.
Rats heavily exposed to cigarette smoke (20 cigarettes a
day) for 6 weeks develop diffuse emphysema and inter-
stitial pneumonia characterized by macrophage-rich inflam-
mation.
36 We also found parenchymal infiltration and
increased macrophage count in alveolar spaces in the group
exposed to tobacco smoke.
To our knowledge, there are only two previous animal
studies on exposure to biomass smoke, one of which
examined the acute effects of cigarette and biomass smoke
13
and the other focused on the chronic effects of only biomass
smoke.
14 Fidan et al. exposed rabbits to cigarette and
biomass smoke for one month.
13 Intraparenchymal vascular
congestion and thrombosis, intraparenchymal hemorrhage,
respiratory epithelial proliferation, macrophages within
alveolar and bronchial lumina, and bronchoalveolar hemor-
rhage were higher in the cigarette-exposed group than in
the control group.
13 Apart from intraparenchymal vascular
thrombosis and bronchoalveolar hemorrhage, we had
similar pathologic findings. However, we found that
perivascular inflammation, peribronchial inflammation,
parenchymal infiltration, and fibrosis were also significantly
increased. This difference can be attributed to the longer
exposure time to cigarette smoke in our study, and our
results reveal that chronic exposure causes an increase in
severity and types of lung injury. In the study mentioned
above, the biomass smoke-exposed group showed respira-
tory epithelial proliferation, alveolar destruction, and
emphysematous changes exclusively.
13 In our study, the
similarly treated group showed no respiratory epithelial
proliferation, but differed from the control group with
respect to perivascular inflammation, peribronchial inflam-
mation, parenchymal infiltration and fibrosis, and nodular
aggregation. This difference is again attributable to chronic
exposure. Both studies indicate that acute or chronic
exposure to cigarette smoke causes more pathological
alterations than biomass smoke. Pathological changes in
the group with combined exposure to cigarette and biomass
smoke were more prominent than those in the group with
exclusive exposure to biomass smoke, but were similar to
those in the group with exclusive exposure to cigarette
smoke. There are no other studies on concurrent and
chronic exposure to tobacco and biomass with which to
compare our findings.
Ozbay et al. exposed rat groups to biomass smoke for 3, 6,
or 9 months.
14 They demonstrated that exposure to the
smoke of dried dung caused chronic inflammatory and
premalignant changes in various parts of the respira-
tory system, including trachea, bronchioles, pulmonary
Figure 5 - Histopathological findings in the cigarette and biomass
smoke-exposed group (Group IV). Parenchymal, peribronchial,
and perivascular inflammation (arrow). (H&E, 610).
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1085interstitium, and lung vessels. Perivascular inflammation,
peribronchial inflammation, and parenchymal fibrosis were
of moderate severity by the end of three and six months.
14
Our biomass smoke-exposed group presented similar
pathological findings. However, we found severe perivas-
cular inflammation, peribronchial inflammation, and par-
enchymal fibrosis at the end of the sixth month but no
changes in the trachea. Ozbay et al. identified hypertrophic
changes in vessel walls accompanied by perivascular
infiltration of lymphocytes, macrophages, and eosinophils
and they suggested that this could result in pulmonary
hypertension.
14 While we found intense perivascular
inflammation in the biomass smoke-exposed group, there
were no increases in alveolar or interstitial macrophage
counts or in vascular wall thickness. There were increases in
alveolar and interstitial deposit-containing macrophage
counts, vascular wall thickness, and intraparenchymal
vascular thrombosis in the group with combined exposure
to biomass and cigarette smoke. We believe that pulmonary
hypertension may result from this process.
Several studies on experimental animals have demon-
strated that exposure to cigarette smoke can cause histo-
pathological alterations in lungs, such as emphysema, small
airway remodeling, vascular remodeling (pulmonary
hypertension), and mucus hypersecretion in large airways
(chronic bronchitis). Exposure to cigarette smoke must last
for at least 6 months for these changes to occur.
37 In their
study on induced myocardial infarction in rats, Duarte et al.
also exposed rats to tobacco smoke for 6 months.
38 The fact
that long term biomass smoke exposure can lead to these
changes has only been shown by one previous study
14 and
there is no existing data about the damage to respiratory
system in the setting of coexisting, long-term exposure to
cigarette and biomass smoke. Therefore, our study is the
first to investigate this issue and has significant impact for
women and children in developing countries that are
subjected to long-term passive exposure to tobacco and
biomass smoke.
The major limitation of this study involves the interpreta-
tion of emphysematous changes. In order to perform a
precise assessment of emphysema, lung tissues should be
inflated under a constant pressure.
39 This methodology was
not followed in our study since the primary objective was
not to obtain an emphysema model. Our aim was to
examine, without additional interference, the possible
impact of chronic passive exposure to indoor fumes by
creating a simulation setting.
CONCLUSION
This study demonstrates that exposure to biomass smoke
causes serious damage to the respiratory system, especially
with concomitant cigarette smoke exposure. Therefore, it is
recommended that in developing countries the use of
biomass for heating and cooking purposes should be
limited. When it is absolutely necessary, it should be used
in ventilated areas. Furthermore, smoking should be
avoided to reduce combined long-term effects.
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